Cargando…

MicroRNAs as Potential Biomarkers in Atherosclerosis

Atherosclerosis is a complex multifactorial disease that, despite advances in lifestyle management and drug therapy, remains to be the major cause of high morbidity and mortality rates from cardiovascular diseases (CVDs) in industrialized countries. Therefore, there is a great need in reliable diagn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Churov, Alexey, Summerhill, Volha, Grechko, Andrey, Orekhova, Varvara, Orekhov, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887712/ https://www.ncbi.nlm.nih.gov/pubmed/31703274 http://dx.doi.org/10.3390/ijms20225547

Ejemplares similares

Vasculoprotective Role of Olive Oil Compounds via Modulation of Oxidative Stress in Atherosclerosis
por: Summerhill, Volha, et al.
Publicado: (2018)

The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
por: Summerhill, Volha I., et al.
Publicado: (2019)

Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque
por: Mushenkova, Nataliya V., et al.
Publicado: (2020)

Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis
por: Salnikova, Diana, et al.
Publicado: (2021)

NADPH Oxidases and Their Role in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
por: Churov, Alexey V., et al.
Publicado: (2023)

MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
por: Solly, Emma L., et al.
Publicado: (2019)

Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease
por: Volobueva, Aleksandrina, et al.
Publicado: (2019)

In Search for Genes Related to Atherosclerosis and Dyslipidemia Using Animal Models
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

Chemokines and microRNAs in atherosclerosis
por: Hartmann, Petra, et al.
Publicado: (2015)

The role of monocytosis and neutrophilia in atherosclerosis
por: Chistiakov, Dimitry A., et al.
Publicado: (2018)

Calcifying Matrix Vesicles and Atherosclerosis
por: Chistiakov, Dimitry A., et al.
Publicado: (2017)

Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development
por: Mushenkova, Nataliya V., et al.
Publicado: (2021)

Roles of microRNAs in atherosclerosis and restenosis
por: Chen, Li-Jing, et al.
Publicado: (2012)

Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells
por: Chistiakov, Dimitry A., et al.
Publicado: (2019)

The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis
por: Shemiakova, Taisiia, et al.
Publicado: (2020)

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

Sex-Specific Features of Calcific Aortic Valve Disease
por: Summerhill, Volha I., et al.
Publicado: (2020)

Functional Phenotypes of Intraplaque Macrophages and Their Distinct Roles in Atherosclerosis Development and Atheroinflammation
por: Mushenkova, Nataliya V., et al.
Publicado: (2022)

The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
por: Poznyak, Anastasia, et al.
Publicado: (2020)

Atherosclerosis in HIV Patients: What Do We Know so Far?
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Lipid‐based gene delivery to macrophage mitochondria for atherosclerosis therapy
por: Zakirov, Felix H., et al.
Publicado: (2020)

Circulating MicroRNAs: Potential Biomarkers for Cancer
por: Yu, De-Cai, et al.
Publicado: (2011)

MicroRNAs as Potential Biomarkers in Pituitary Adenomas
por: Donati, Simone, et al.
Publicado: (2021)

MicroRNAs as Potential Biomarkers in Gynecological Cancers
por: Miśkiewicz, Joanna, et al.
Publicado: (2023)

Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis
por: Jahangir, Zainab, et al.
Publicado: (2018)

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease
por: Blagov, Alexander V., et al.
Publicado: (2023)

Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis
por: Griñán, Raquel, et al.
Publicado: (2022)

Circulating MicroRNAs as Potential Biomarkers of Exercise Response
por: Polakovičová, Mája, et al.
Publicado: (2016)

MicroRNAs as Potential Biomarkers in Merkel Cell Carcinoma
por: Konstantinell, Aelita, et al.
Publicado: (2018)

MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022)

Local Accumulation of Lymphocytes in the Intima of Human Aorta Is Associated with Giant Multinucleated Endothelial Cells: Possible Explanation for Mosaicism of Atherosclerosis
por: Nikiforov, Nikita G., et al.
Publicado: (2022)

MicroRNAs as Biomarkers in Cancer
por: Sundarbose, Kamini, et al.
Publicado: (2013)

MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications
por: Li, Zhaoyi, et al.
Publicado: (2023)

MicroRNAs as Potential Biomarkers of Post-Traumatic Epileptogenesis: A Systematic Review
por: Vasilieva, Anastasia A., et al.
Publicado: (2023)

MicroRNAs as Potential Mediators for Cigarette Smoking Induced Atherosclerosis
por: Yokoyama, Yuka, et al.
Publicado: (2018)

In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cguvvsbl5f4quj96h6lhf465cv